Science and Research

Distinct IL-1alpha-responsive enhancers promote acute and coordinated changes in chromatin topology in a hierarchical manner

How cytokine-driven changes in chromatin topology are converted into gene regulatory circuits during inflammation still remains unclear. Here, we show that interleukin (IL)-1alpha induces acute and widespread changes in chromatin accessibility via the TAK1 kinase and NF-kappaB at regions that are highly enriched for inflammatory disease-relevant SNPs. Two enhancers in the extended chemokine locus on human chromosome 4 regulate the IL-1alpha-inducible IL8 and CXCL1-3 genes. Both enhancers engage in dynamic spatial interactions with gene promoters in an IL-1alpha/TAK1-inducible manner. Microdeletions of p65-binding sites in either of the two enhancers impair NF-kappaB recruitment, suppress activation and biallelic transcription of the IL8/CXCL2 genes, and reshuffle higher-order chromatin interactions as judged by i4C interactome profiles. Notably, these findings support a dominant role of the IL8 "master" enhancer in the regulation of sustained IL-1alpha signaling, as well as for IL-8 and IL-6 secretion. CRISPR-guided transactivation of the IL8 locus or cross-TAD regulation by TNFalpha-responsive enhancers in a different model locus supports the existence of complex enhancer hierarchies in response to cytokine stimulation that prime and orchestrate proinflammatory chromatin responses downstream of NF-kappaB.

  • Weiterer, S. S.
  • Meier-Soelch, J.
  • Georgomanolis, T.
  • Mizi, A.
  • Beyerlein, A.
  • Weiser, H.
  • Brant, L.
  • Mayr-Buro, C.
  • Jurida, L.
  • Beuerlein, K.
  • Muller, H.
  • Weber, A.
  • Tenekeci, U.
  • Dittrich-Breiholz, O.
  • Bartkuhn, M.
  • Nist, A.
  • Stiewe, T.
  • van, IJcken W. F.
  • Riedlinger, T.
  • Schmitz, M. L.
  • Papantonis, A.
  • Kracht, M.

Keywords

  • Binding Sites
  • Cells, Cultured
  • Chemokines/metabolism
  • Chromatin/chemistry/genetics/*metabolism
  • Enhancer Elements, Genetic/*genetics
  • Gene Expression Regulation/*drug effects
  • HeLa Cells
  • Humans
  • Inflammation Mediators/*metabolism
  • Interleukin-1alpha/*pharmacology
  • MAP Kinase Kinase Kinases/genetics/*metabolism
  • NF-kappa B/genetics/*metabolism
  • Signal Transduction
  • Tumor Necrosis Factor-alpha/pharmacology
  • *il-8
  • *NF-kappaB
  • *chromatin topology
  • *interleukin-1
  • *tumor necrosis factor-alpha
Publication details
DOI: 10.15252/embj.2019101533
Journal: EMBO J
Pages: e101533 
Number: 1
Work Type: Original
Location: BREATH, UGMLC
Disease Area: PALI
Partner / Member: JLU, MHH, UMR
Access-Number: 31701553
See publication on PubMed

DZL Engagements

chevron-down